Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
The enigma of microvascular and macrovascular changes in mild essential hypertension..
J Hypertens. 32(7), 1544.
(2014). Endothelial Microvesicles Circulating in Peripheral and Coronary Circulation Are Associated With Central Blood Pressure in Coronary Artery Disease..
Am J Hypertens. 32(12), 1199-1205.
(2019). Platelet activation in essential hypertension during exercise: pre- and post-treatment changes with an angiotensin II receptor blocker..
Am J Hypertens. 27(4), 571-8.
(2014). The pathogenesis of arterial stiffness and its prognostic value in essential hypertension and cardiovascular diseases..
Hippokratia. 13(2), 70-5.
(2009). Platelet activation in essential hypertension: implications for antiplatelet treatment..
Am J Hypertens. 23(3), 229-36.
(2010). Clinical Significance of Endothelial Dysfunction in Essential Hypertension..
Curr Hypertens Rep. 17(11), 85.
(2015). Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension..
J Hypertens. 27(12), 2310-20.
(2009). Clinical impact of dipping and nocturnal blood pressure patterns in newly diagnosed, never-treated patients with essential hypertension..
J Am Soc Hypertens. 12(12), 850-857.
(2018). PATHWAY-2: spironolactone for resistant hypertension..
Lancet. 387(10026), 1372.
(2016). Asymmetric dimethylarginine levels are associated with augmentation index across naïve untreated patients with different hypertension phenotypes..
J Clin Hypertens (Greenwich). 20(4), 680-685.
(2018).
(2020). Association between cardiotrophin 1 levels and central blood pressure in untreated patients with essential hypertension..
Am J Hypertens. 27(5), 651-5.
(2014). Plasma renin activity to plasma aldosterone concentration ratio for the assessment of essential hypertensive patients in real-life clinical practice..
J Hypertens. 36(2), 444.
(2018). Cardiovascular risk in psoriatic arthritis: should we focus on hypertension and diabetes only?.
Clin Exp Rheumatol. 32(6), 995.
(2014). Antiplatelet treatment in essential hypertension: where do we stand?.
Curr Hypertens Rep. 17(4), 536.
(2015). Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension..
Eur Heart J. 30(24), 3048-54.
(2009). The putative role of vitamin D in essential hypertension: stepping into the light?.
Am J Hypertens. 27(7), 985-6.
(2014). Reply to: Seeing the forest, but not the trees: pertinent considerations for examining acute changes in pulse wave velocity in response to pharmaceutical interventions and exercise..
J Clin Hypertens (Greenwich). 16(10), 769.
(2014). Exercise-induced platelet activation in essential hypertension: have we solved the puzzle?.
J Hypertens. 31(9), 1915-6.
(2013). Aldosterone as a mediator of microvascular and macrovascular damage in a population of normotensive to early-stage hypertensive individuals..
J Am Soc Hypertens. 12(1), 50-57.
(2018). Primary posterior mediastinal germ cell tumor in a child..
Turk Pediatri Ars. 54(3), 185-188.
(2019). Emerging genetic influences in benign epilepsy with centro-temporal spikes - BECTS..
Epilepsy Res. 101(3), 197-201.
(2012). Primary posterior mediastinal germ cell tumor in a child..
Turk Pediatri Ars. 54(3), 185-188.
(2019). Association of brain-derived neurotrophic factor (BDNF) and elongator protein complex 4 (ELP4) polymorphisms with benign epilepsy with centrotemporal spikes in a Greek population..
Epilepsy Res. 108(10), 1734-9.
(2014). Ketosis and EEG improvement following viral gastroenteritis in patient with West syndrome..
Brain Dev. 36(5), 411-2.
(2014).